ClariFlow
An innovative kit detects early clots and uses safe enzymes and nattokinase therapy to dissolve them, offering targeted protection for transgender women and reducing healthcare inequality.
An innovative kit detects early clots and uses safe enzymes and nattokinase therapy to dissolve them, offering targeted protection for transgender women and reducing healthcare inequality.
Log in or sign up for Devpost to join the conversation.